nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—SLCO1B3—Docetaxel—pancreatic cancer	0.101	0.174	CbGbCtD
Liotrix—SLCO1B1—Irinotecan—pancreatic cancer	0.08	0.138	CbGbCtD
Liotrix—ALB—Erlotinib—pancreatic cancer	0.0485	0.0838	CbGbCtD
Liotrix—CYP2C8—Tamoxifen—pancreatic cancer	0.0441	0.0761	CbGbCtD
Liotrix—ALB—Irinotecan—pancreatic cancer	0.0438	0.0757	CbGbCtD
Liotrix—ALB—Fluorouracil—pancreatic cancer	0.0421	0.0726	CbGbCtD
Liotrix—CYP2C8—Erlotinib—pancreatic cancer	0.0375	0.0647	CbGbCtD
Liotrix—CYP2C8—Fluorouracil—pancreatic cancer	0.0325	0.0561	CbGbCtD
Liotrix—ABCB1—Tamoxifen—pancreatic cancer	0.0299	0.0515	CbGbCtD
Liotrix—ABCB1—Gemcitabine—pancreatic cancer	0.0257	0.0444	CbGbCtD
Liotrix—SLC10A1—bile duct—pancreatic cancer	0.0254	0.379	CbGeAlD
Liotrix—ABCB1—Erlotinib—pancreatic cancer	0.0254	0.0438	CbGbCtD
Liotrix—ABCB1—Irinotecan—pancreatic cancer	0.0229	0.0396	CbGbCtD
Liotrix—SLC10A1—bile—pancreatic cancer	0.0195	0.291	CbGeAlD
Liotrix—ABCB1—Docetaxel—pancreatic cancer	0.0168	0.029	CbGbCtD
Liotrix—ABCB1—Sunitinib—pancreatic cancer	0.0167	0.0289	CbGbCtD
Liotrix—ABCB1—Doxorubicin—pancreatic cancer	0.0125	0.0216	CbGbCtD
Liotrix—TTR—islet of Langerhans—pancreatic cancer	0.00298	0.0445	CbGeAlD
Liotrix—ALB—gall bladder—pancreatic cancer	0.0029	0.0434	CbGeAlD
Liotrix—SLCO4A1—islet of Langerhans—pancreatic cancer	0.00267	0.0399	CbGeAlD
Liotrix—SLC10A1—digestive system—pancreatic cancer	0.00213	0.0318	CbGeAlD
Liotrix—TTR—pancreas—pancreatic cancer	0.0021	0.0313	CbGeAlD
Liotrix—SLCO4A1—pancreas—pancreatic cancer	0.00188	0.0281	CbGeAlD
Liotrix—TTR—digestive system—pancreatic cancer	0.00179	0.0267	CbGeAlD
Liotrix—SLCO4A1—digestive system—pancreatic cancer	0.00161	0.024	CbGeAlD
Liotrix—SLCO1B1—digestive system—pancreatic cancer	0.00141	0.0211	CbGeAlD
Liotrix—SLCO1A2—digestive system—pancreatic cancer	0.00115	0.0172	CbGeAlD
Liotrix—ABCB1—islet of Langerhans—pancreatic cancer	0.000642	0.00958	CbGeAlD
Liotrix—ABCB1—pancreas—pancreatic cancer	0.000451	0.00673	CbGeAlD
Liotrix—ABCB1—digestive system—pancreatic cancer	0.000385	0.00575	CbGeAlD
Liotrix—Hypotension—Irinotecan—pancreatic cancer	0.000309	0.00125	CcSEcCtD
Liotrix—Increased appetite—Doxorubicin—pancreatic cancer	0.000309	0.00125	CcSEcCtD
Liotrix—Affect lability—Epirubicin—pancreatic cancer	0.000309	0.00125	CcSEcCtD
Liotrix—Anorexia—Gemcitabine—pancreatic cancer	0.000307	0.00124	CcSEcCtD
Liotrix—Dizziness—Erlotinib—pancreatic cancer	0.000307	0.00124	CcSEcCtD
Liotrix—Renal impairment—Doxorubicin—pancreatic cancer	0.000305	0.00123	CcSEcCtD
Liotrix—Anorexia—Fluorouracil—pancreatic cancer	0.000302	0.00122	CcSEcCtD
Liotrix—Hypotension—Gemcitabine—pancreatic cancer	0.000301	0.00122	CcSEcCtD
Liotrix—Insomnia—Irinotecan—pancreatic cancer	0.000299	0.00121	CcSEcCtD
Liotrix—Flushing—Docetaxel—pancreatic cancer	0.000299	0.00121	CcSEcCtD
Liotrix—Cardiac arrest—Epirubicin—pancreatic cancer	0.000299	0.00121	CcSEcCtD
Liotrix—Vomiting—Tamoxifen—pancreatic cancer	0.000298	0.0012	CcSEcCtD
Liotrix—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000298	0.0012	CcSEcCtD
Liotrix—Cardiac failure—Doxorubicin—pancreatic cancer	0.000298	0.0012	CcSEcCtD
Liotrix—Mood swings—Epirubicin—pancreatic cancer	0.000298	0.0012	CcSEcCtD
Liotrix—Paraesthesia—Irinotecan—pancreatic cancer	0.000297	0.0012	CcSEcCtD
Liotrix—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000297	0.0012	CcSEcCtD
Liotrix—Hypotension—Fluorouracil—pancreatic cancer	0.000296	0.0012	CcSEcCtD
Liotrix—Hypersensitivity—Sunitinib—pancreatic cancer	0.000296	0.00119	CcSEcCtD
Liotrix—Rash—Tamoxifen—pancreatic cancer	0.000296	0.00119	CcSEcCtD
Liotrix—Dermatitis—Tamoxifen—pancreatic cancer	0.000296	0.00119	CcSEcCtD
Liotrix—Vomiting—Erlotinib—pancreatic cancer	0.000295	0.00119	CcSEcCtD
Liotrix—Dyspnoea—Irinotecan—pancreatic cancer	0.000295	0.00119	CcSEcCtD
Liotrix—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000294	0.00119	CcSEcCtD
Liotrix—Headache—Tamoxifen—pancreatic cancer	0.000294	0.00119	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000294	0.00119	CcSEcCtD
Liotrix—Rash—Erlotinib—pancreatic cancer	0.000293	0.00118	CcSEcCtD
Liotrix—Dermatitis—Erlotinib—pancreatic cancer	0.000292	0.00118	CcSEcCtD
Liotrix—Dehydration—Epirubicin—pancreatic cancer	0.000292	0.00118	CcSEcCtD
Liotrix—Insomnia—Gemcitabine—pancreatic cancer	0.000292	0.00118	CcSEcCtD
Liotrix—Headache—Erlotinib—pancreatic cancer	0.000291	0.00117	CcSEcCtD
Liotrix—Paraesthesia—Gemcitabine—pancreatic cancer	0.00029	0.00117	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000289	0.00117	CcSEcCtD
Liotrix—Asthenia—Sunitinib—pancreatic cancer	0.000288	0.00116	CcSEcCtD
Liotrix—Decreased appetite—Irinotecan—pancreatic cancer	0.000288	0.00116	CcSEcCtD
Liotrix—Arrhythmia—Docetaxel—pancreatic cancer	0.000288	0.00116	CcSEcCtD
Liotrix—Dyspnoea—Gemcitabine—pancreatic cancer	0.000288	0.00116	CcSEcCtD
Liotrix—Insomnia—Fluorouracil—pancreatic cancer	0.000287	0.00116	CcSEcCtD
Liotrix—Affect lability—Doxorubicin—pancreatic cancer	0.000286	0.00115	CcSEcCtD
Liotrix—Hypokalaemia—Epirubicin—pancreatic cancer	0.000286	0.00115	CcSEcCtD
Liotrix—Fatigue—Irinotecan—pancreatic cancer	0.000285	0.00115	CcSEcCtD
Liotrix—Paraesthesia—Fluorouracil—pancreatic cancer	0.000285	0.00115	CcSEcCtD
Liotrix—Alopecia—Docetaxel—pancreatic cancer	0.000285	0.00115	CcSEcCtD
Liotrix—Pruritus—Sunitinib—pancreatic cancer	0.000284	0.00115	CcSEcCtD
Liotrix—Constipation—Irinotecan—pancreatic cancer	0.000283	0.00114	CcSEcCtD
Liotrix—Dyspnoea—Fluorouracil—pancreatic cancer	0.000283	0.00114	CcSEcCtD
Liotrix—Decreased appetite—Gemcitabine—pancreatic cancer	0.00028	0.00113	CcSEcCtD
Liotrix—Nausea—Tamoxifen—pancreatic cancer	0.000279	0.00112	CcSEcCtD
Liotrix—Fatigue—Gemcitabine—pancreatic cancer	0.000278	0.00112	CcSEcCtD
Liotrix—Muscular weakness—Epirubicin—pancreatic cancer	0.000277	0.00112	CcSEcCtD
Liotrix—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000276	0.00112	CcSEcCtD
Liotrix—Constipation—Gemcitabine—pancreatic cancer	0.000276	0.00111	CcSEcCtD
Liotrix—Nausea—Erlotinib—pancreatic cancer	0.000276	0.00111	CcSEcCtD
Liotrix—Decreased appetite—Fluorouracil—pancreatic cancer	0.000276	0.00111	CcSEcCtD
Liotrix—Mood swings—Doxorubicin—pancreatic cancer	0.000275	0.00111	CcSEcCtD
Liotrix—Diarrhoea—Sunitinib—pancreatic cancer	0.000275	0.00111	CcSEcCtD
Liotrix—Dysgeusia—Docetaxel—pancreatic cancer	0.000275	0.00111	CcSEcCtD
Liotrix—Abdominal distension—Epirubicin—pancreatic cancer	0.000273	0.0011	CcSEcCtD
Liotrix—Feeling abnormal—Irinotecan—pancreatic cancer	0.000273	0.0011	CcSEcCtD
Liotrix—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000272	0.0011	CcSEcCtD
Liotrix—Dysphagia—Epirubicin—pancreatic cancer	0.000271	0.0011	CcSEcCtD
Liotrix—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000271	0.00109	CcSEcCtD
Liotrix—Dehydration—Doxorubicin—pancreatic cancer	0.00027	0.00109	CcSEcCtD
Liotrix—Dizziness—Sunitinib—pancreatic cancer	0.000266	0.00107	CcSEcCtD
Liotrix—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000266	0.00107	CcSEcCtD
Liotrix—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000264	0.00107	CcSEcCtD
Liotrix—Angina pectoris—Epirubicin—pancreatic cancer	0.000264	0.00107	CcSEcCtD
Liotrix—Body temperature increased—Irinotecan—pancreatic cancer	0.000262	0.00106	CcSEcCtD
Liotrix—Abdominal pain—Irinotecan—pancreatic cancer	0.000262	0.00106	CcSEcCtD
Liotrix—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000261	0.00105	CcSEcCtD
Liotrix—Bronchitis—Epirubicin—pancreatic cancer	0.000261	0.00105	CcSEcCtD
Liotrix—Muscular weakness—Doxorubicin—pancreatic cancer	0.000256	0.00103	CcSEcCtD
Liotrix—Vomiting—Sunitinib—pancreatic cancer	0.000256	0.00103	CcSEcCtD
Liotrix—Body temperature increased—Gemcitabine—pancreatic cancer	0.000255	0.00103	CcSEcCtD
Liotrix—Rash—Sunitinib—pancreatic cancer	0.000253	0.00102	CcSEcCtD
Liotrix—Dermatitis—Sunitinib—pancreatic cancer	0.000253	0.00102	CcSEcCtD
Liotrix—Abdominal distension—Doxorubicin—pancreatic cancer	0.000253	0.00102	CcSEcCtD
Liotrix—Urticaria—Fluorouracil—pancreatic cancer	0.000252	0.00102	CcSEcCtD
Liotrix—Headache—Sunitinib—pancreatic cancer	0.000252	0.00102	CcSEcCtD
Liotrix—Syncope—Docetaxel—pancreatic cancer	0.000251	0.00101	CcSEcCtD
Liotrix—Dysphagia—Doxorubicin—pancreatic cancer	0.000251	0.00101	CcSEcCtD
Liotrix—Body temperature increased—Fluorouracil—pancreatic cancer	0.000251	0.00101	CcSEcCtD
Liotrix—Palpitations—Docetaxel—pancreatic cancer	0.000248	0.001	CcSEcCtD
Liotrix—Loss of consciousness—Docetaxel—pancreatic cancer	0.000246	0.000995	CcSEcCtD
Liotrix—Weight decreased—Epirubicin—pancreatic cancer	0.000246	0.000991	CcSEcCtD
Liotrix—Angina pectoris—Doxorubicin—pancreatic cancer	0.000245	0.000987	CcSEcCtD
Liotrix—Hypersensitivity—Irinotecan—pancreatic cancer	0.000244	0.000984	CcSEcCtD
Liotrix—Convulsion—Docetaxel—pancreatic cancer	0.000243	0.00098	CcSEcCtD
Liotrix—Hypertension—Docetaxel—pancreatic cancer	0.000242	0.000977	CcSEcCtD
Liotrix—Bronchitis—Doxorubicin—pancreatic cancer	0.000242	0.000975	CcSEcCtD
Liotrix—Arthralgia—Docetaxel—pancreatic cancer	0.000239	0.000963	CcSEcCtD
Liotrix—Chest pain—Docetaxel—pancreatic cancer	0.000239	0.000963	CcSEcCtD
Liotrix—Nausea—Sunitinib—pancreatic cancer	0.000239	0.000963	CcSEcCtD
Liotrix—Renal failure—Epirubicin—pancreatic cancer	0.000238	0.00096	CcSEcCtD
Liotrix—Asthenia—Irinotecan—pancreatic cancer	0.000238	0.000959	CcSEcCtD
Liotrix—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000234	0.000943	CcSEcCtD
Liotrix—Sweating—Epirubicin—pancreatic cancer	0.000232	0.000936	CcSEcCtD
Liotrix—Asthenia—Gemcitabine—pancreatic cancer	0.000231	0.000934	CcSEcCtD
Liotrix—Confusional state—Docetaxel—pancreatic cancer	0.000231	0.000931	CcSEcCtD
Liotrix—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000229	0.000924	CcSEcCtD
Liotrix—Oedema—Docetaxel—pancreatic cancer	0.000229	0.000924	CcSEcCtD
Liotrix—Pruritus—Gemcitabine—pancreatic cancer	0.000228	0.000921	CcSEcCtD
Liotrix—Infection—Docetaxel—pancreatic cancer	0.000227	0.000918	CcSEcCtD
Liotrix—Weight decreased—Doxorubicin—pancreatic cancer	0.000227	0.000917	CcSEcCtD
Liotrix—Diarrhoea—Irinotecan—pancreatic cancer	0.000227	0.000914	CcSEcCtD
Liotrix—Shock—Docetaxel—pancreatic cancer	0.000225	0.000909	CcSEcCtD
Liotrix—Pruritus—Fluorouracil—pancreatic cancer	0.000224	0.000905	CcSEcCtD
Liotrix—Tachycardia—Docetaxel—pancreatic cancer	0.000223	0.000901	CcSEcCtD
Liotrix—Diarrhoea—Gemcitabine—pancreatic cancer	0.000221	0.00089	CcSEcCtD
Liotrix—Renal failure—Doxorubicin—pancreatic cancer	0.00022	0.000888	CcSEcCtD
Liotrix—Dizziness—Irinotecan—pancreatic cancer	0.000219	0.000883	CcSEcCtD
Liotrix—Anorexia—Docetaxel—pancreatic cancer	0.000218	0.00088	CcSEcCtD
Liotrix—Diarrhoea—Fluorouracil—pancreatic cancer	0.000217	0.000876	CcSEcCtD
Liotrix—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000216	0.000872	CcSEcCtD
Liotrix—Sweating—Doxorubicin—pancreatic cancer	0.000215	0.000866	CcSEcCtD
Liotrix—Hypotension—Docetaxel—pancreatic cancer	0.000214	0.000863	CcSEcCtD
Liotrix—Vomiting—Irinotecan—pancreatic cancer	0.00021	0.000849	CcSEcCtD
Liotrix—Dizziness—Fluorouracil—pancreatic cancer	0.00021	0.000846	CcSEcCtD
Liotrix—Rash—Irinotecan—pancreatic cancer	0.000209	0.000842	CcSEcCtD
Liotrix—Dermatitis—Irinotecan—pancreatic cancer	0.000209	0.000842	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000209	0.000841	CcSEcCtD
Liotrix—Headache—Irinotecan—pancreatic cancer	0.000207	0.000837	CcSEcCtD
Liotrix—Insomnia—Docetaxel—pancreatic cancer	0.000207	0.000835	CcSEcCtD
Liotrix—Paraesthesia—Docetaxel—pancreatic cancer	0.000205	0.000829	CcSEcCtD
Liotrix—Vomiting—Gemcitabine—pancreatic cancer	0.000205	0.000827	CcSEcCtD
Liotrix—Dyspnoea—Docetaxel—pancreatic cancer	0.000204	0.000823	CcSEcCtD
Liotrix—Rash—Gemcitabine—pancreatic cancer	0.000203	0.000821	CcSEcCtD
Liotrix—Dermatitis—Gemcitabine—pancreatic cancer	0.000203	0.00082	CcSEcCtD
Liotrix—Headache—Gemcitabine—pancreatic cancer	0.000202	0.000815	CcSEcCtD
Liotrix—Flushing—Epirubicin—pancreatic cancer	0.000202	0.000814	CcSEcCtD
Liotrix—Vomiting—Fluorouracil—pancreatic cancer	0.000202	0.000814	CcSEcCtD
Liotrix—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.0002	0.000807	CcSEcCtD
Liotrix—Rash—Fluorouracil—pancreatic cancer	0.0002	0.000807	CcSEcCtD
Liotrix—Dermatitis—Fluorouracil—pancreatic cancer	0.0002	0.000806	CcSEcCtD
Liotrix—Decreased appetite—Docetaxel—pancreatic cancer	0.000199	0.000803	CcSEcCtD
Liotrix—Headache—Fluorouracil—pancreatic cancer	0.000199	0.000802	CcSEcCtD
Liotrix—Fatigue—Docetaxel—pancreatic cancer	0.000197	0.000796	CcSEcCtD
Liotrix—Nausea—Irinotecan—pancreatic cancer	0.000197	0.000794	CcSEcCtD
Liotrix—Constipation—Docetaxel—pancreatic cancer	0.000196	0.00079	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—pancreatic cancer	0.000194	0.000783	CcSEcCtD
Liotrix—Alopecia—Epirubicin—pancreatic cancer	0.000192	0.000775	CcSEcCtD
Liotrix—Nausea—Gemcitabine—pancreatic cancer	0.000192	0.000773	CcSEcCtD
Liotrix—Feeling abnormal—Docetaxel—pancreatic cancer	0.000189	0.000761	CcSEcCtD
Liotrix—Nausea—Fluorouracil—pancreatic cancer	0.000188	0.00076	CcSEcCtD
Liotrix—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000187	0.000755	CcSEcCtD
Liotrix—Flushing—Doxorubicin—pancreatic cancer	0.000187	0.000753	CcSEcCtD
Liotrix—Flatulence—Epirubicin—pancreatic cancer	0.000186	0.000752	CcSEcCtD
Liotrix—Tension—Epirubicin—pancreatic cancer	0.000186	0.000749	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—pancreatic cancer	0.000185	0.000747	CcSEcCtD
Liotrix—Nervousness—Epirubicin—pancreatic cancer	0.000184	0.000741	CcSEcCtD
Liotrix—Abdominal pain—Docetaxel—pancreatic cancer	0.000181	0.00073	CcSEcCtD
Liotrix—Body temperature increased—Docetaxel—pancreatic cancer	0.000181	0.00073	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—pancreatic cancer	0.00018	0.000725	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—pancreatic cancer	0.000178	0.000719	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—pancreatic cancer	0.000178	0.000717	CcSEcCtD
Liotrix—Agitation—Epirubicin—pancreatic cancer	0.000174	0.000701	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—pancreatic cancer	0.000172	0.000696	CcSEcCtD
Liotrix—Tension—Doxorubicin—pancreatic cancer	0.000172	0.000693	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—pancreatic cancer	0.000171	0.000692	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—pancreatic cancer	0.00017	0.000686	CcSEcCtD
Liotrix—Syncope—Epirubicin—pancreatic cancer	0.00017	0.000684	CcSEcCtD
Liotrix—Hypersensitivity—Docetaxel—pancreatic cancer	0.000169	0.00068	CcSEcCtD
Liotrix—Palpitations—Epirubicin—pancreatic cancer	0.000167	0.000675	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—pancreatic cancer	0.000166	0.000671	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—pancreatic cancer	0.000165	0.000666	CcSEcCtD
Liotrix—Asthenia—Docetaxel—pancreatic cancer	0.000164	0.000663	CcSEcCtD
Liotrix—Convulsion—Epirubicin—pancreatic cancer	0.000164	0.000661	CcSEcCtD
Liotrix—Hypertension—Epirubicin—pancreatic cancer	0.000163	0.000659	CcSEcCtD
Liotrix—Pruritus—Docetaxel—pancreatic cancer	0.000162	0.000653	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—pancreatic cancer	0.000161	0.00065	CcSEcCtD
Liotrix—Chest pain—Epirubicin—pancreatic cancer	0.000161	0.00065	CcSEcCtD
Liotrix—Agitation—Doxorubicin—pancreatic cancer	0.000161	0.000649	CcSEcCtD
Liotrix—Anxiety—Epirubicin—pancreatic cancer	0.00016	0.000648	CcSEcCtD
Liotrix—Syncope—Doxorubicin—pancreatic cancer	0.000157	0.000633	CcSEcCtD
Liotrix—Diarrhoea—Docetaxel—pancreatic cancer	0.000157	0.000632	CcSEcCtD
Liotrix—Confusional state—Epirubicin—pancreatic cancer	0.000156	0.000628	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—pancreatic cancer	0.000155	0.000624	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000154	0.000623	CcSEcCtD
Liotrix—Oedema—Epirubicin—pancreatic cancer	0.000154	0.000623	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000154	0.000621	CcSEcCtD
Liotrix—Infection—Epirubicin—pancreatic cancer	0.000153	0.000619	CcSEcCtD
Liotrix—Shock—Epirubicin—pancreatic cancer	0.000152	0.000613	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—pancreatic cancer	0.000152	0.000612	CcSEcCtD
Liotrix—Dizziness—Docetaxel—pancreatic cancer	0.000151	0.000611	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—pancreatic cancer	0.000151	0.00061	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—pancreatic cancer	0.000151	0.000608	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000149	0.000602	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—pancreatic cancer	0.000149	0.000601	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—pancreatic cancer	0.000149	0.000601	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—pancreatic cancer	0.000148	0.000599	CcSEcCtD
Liotrix—Anorexia—Epirubicin—pancreatic cancer	0.000147	0.000594	CcSEcCtD
Liotrix—Vomiting—Docetaxel—pancreatic cancer	0.000146	0.000587	CcSEcCtD
Liotrix—Rash—Docetaxel—pancreatic cancer	0.000144	0.000582	CcSEcCtD
Liotrix—Hypotension—Epirubicin—pancreatic cancer	0.000144	0.000582	CcSEcCtD
Liotrix—Dermatitis—Docetaxel—pancreatic cancer	0.000144	0.000582	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—pancreatic cancer	0.000144	0.000581	CcSEcCtD
Liotrix—Headache—Docetaxel—pancreatic cancer	0.000143	0.000579	CcSEcCtD
Liotrix—Oedema—Doxorubicin—pancreatic cancer	0.000143	0.000576	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000143	0.000576	CcSEcCtD
Liotrix—Infection—Doxorubicin—pancreatic cancer	0.000142	0.000573	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000141	0.000568	CcSEcCtD
Liotrix—Shock—Doxorubicin—pancreatic cancer	0.000141	0.000567	CcSEcCtD
Liotrix—Insomnia—Epirubicin—pancreatic cancer	0.00014	0.000563	CcSEcCtD
Liotrix—Tachycardia—Doxorubicin—pancreatic cancer	0.000139	0.000563	CcSEcCtD
Liotrix—Paraesthesia—Epirubicin—pancreatic cancer	0.000139	0.000559	CcSEcCtD
Liotrix—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000138	0.000557	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—pancreatic cancer	0.000138	0.000555	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—pancreatic cancer	0.000136	0.000549	CcSEcCtD
Liotrix—Nausea—Docetaxel—pancreatic cancer	0.000136	0.000549	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—pancreatic cancer	0.000134	0.000542	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—pancreatic cancer	0.000133	0.000539	CcSEcCtD
Liotrix—Fatigue—Epirubicin—pancreatic cancer	0.000133	0.000537	CcSEcCtD
Liotrix—Constipation—Epirubicin—pancreatic cancer	0.000132	0.000533	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00013	0.000525	CcSEcCtD
Liotrix—Insomnia—Doxorubicin—pancreatic cancer	0.000129	0.000521	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—pancreatic cancer	0.000128	0.000518	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—pancreatic cancer	0.000127	0.000514	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—pancreatic cancer	0.000127	0.000513	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000126	0.000509	CcSEcCtD
Liotrix—Decreased appetite—Doxorubicin—pancreatic cancer	0.000124	0.000501	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—pancreatic cancer	0.000123	0.000497	CcSEcCtD
Liotrix—Urticaria—Epirubicin—pancreatic cancer	0.000123	0.000495	CcSEcCtD
Liotrix—Constipation—Doxorubicin—pancreatic cancer	0.000122	0.000493	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—pancreatic cancer	0.000122	0.000492	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—pancreatic cancer	0.000122	0.000492	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000118	0.000475	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000117	0.000471	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—pancreatic cancer	0.000114	0.000459	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—pancreatic cancer	0.000113	0.000458	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—pancreatic cancer	0.000113	0.000456	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—pancreatic cancer	0.000113	0.000456	CcSEcCtD
Liotrix—Asthenia—Epirubicin—pancreatic cancer	0.000111	0.000447	CcSEcCtD
Liotrix—Pruritus—Epirubicin—pancreatic cancer	0.000109	0.000441	CcSEcCtD
Liotrix—Diarrhoea—Epirubicin—pancreatic cancer	0.000106	0.000426	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000105	0.000425	CcSEcCtD
Liotrix—Asthenia—Doxorubicin—pancreatic cancer	0.000102	0.000414	CcSEcCtD
Liotrix—Dizziness—Epirubicin—pancreatic cancer	0.000102	0.000412	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—pancreatic cancer	0.000101	0.000408	CcSEcCtD
Liotrix—Vomiting—Epirubicin—pancreatic cancer	9.81e-05	0.000396	CcSEcCtD
Liotrix—Diarrhoea—Doxorubicin—pancreatic cancer	9.77e-05	0.000394	CcSEcCtD
Liotrix—Rash—Epirubicin—pancreatic cancer	9.73e-05	0.000393	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—pancreatic cancer	9.72e-05	0.000392	CcSEcCtD
Liotrix—Headache—Epirubicin—pancreatic cancer	9.67e-05	0.00039	CcSEcCtD
Liotrix—Dizziness—Doxorubicin—pancreatic cancer	9.44e-05	0.000381	CcSEcCtD
Liotrix—Nausea—Epirubicin—pancreatic cancer	9.17e-05	0.00037	CcSEcCtD
Liotrix—Vomiting—Doxorubicin—pancreatic cancer	9.08e-05	0.000366	CcSEcCtD
Liotrix—Rash—Doxorubicin—pancreatic cancer	9.01e-05	0.000363	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—pancreatic cancer	9e-05	0.000363	CcSEcCtD
Liotrix—Headache—Doxorubicin—pancreatic cancer	8.95e-05	0.000361	CcSEcCtD
Liotrix—Nausea—Doxorubicin—pancreatic cancer	8.48e-05	0.000342	CcSEcCtD
Liotrix—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	4.41e-05	0.000416	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.33e-05	0.000408	CbGpPWpGaD
Liotrix—TTR—Disease—NOTCH1—pancreatic cancer	4.32e-05	0.000408	CbGpPWpGaD
Liotrix—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	4.31e-05	0.000407	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.29e-05	0.000404	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GLP1R—pancreatic cancer	4.19e-05	0.000395	CbGpPWpGaD
Liotrix—TTR—Disease—EGF—pancreatic cancer	4.18e-05	0.000394	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—DPYD—pancreatic cancer	4.12e-05	0.000388	CbGpPWpGaD
Liotrix—ABCB1—Allograft Rejection—TNF—pancreatic cancer	4.12e-05	0.000388	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SMAD4—pancreatic cancer	4.11e-05	0.000387	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.1e-05	0.000386	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.08e-05	0.000385	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	4.03e-05	0.00038	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HES1—pancreatic cancer	4.01e-05	0.000378	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	3.98e-05	0.000375	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.92e-05	0.00037	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	3.91e-05	0.000369	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—APOE—pancreatic cancer	3.88e-05	0.000366	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.87e-05	0.000365	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CD44—pancreatic cancer	3.85e-05	0.000363	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.77e-05	0.000356	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.74e-05	0.000353	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.73e-05	0.000352	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CD—pancreatic cancer	3.72e-05	0.000351	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—GCG—pancreatic cancer	3.69e-05	0.000348	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.67e-05	0.000346	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.67e-05	0.000346	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CD44—pancreatic cancer	3.65e-05	0.000344	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	3.58e-05	0.000338	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.57e-05	0.000337	CbGpPWpGaD
Liotrix—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	3.54e-05	0.000334	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	3.54e-05	0.000334	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IFNA1—pancreatic cancer	3.53e-05	0.000333	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—DPYD—pancreatic cancer	3.52e-05	0.000332	CbGpPWpGaD
Liotrix—THRA—Gene Expression—MYC—pancreatic cancer	3.52e-05	0.000332	CbGpPWpGaD
Liotrix—THRB—Gene Expression—MYC—pancreatic cancer	3.52e-05	0.000332	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TERT—pancreatic cancer	3.51e-05	0.000331	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CG—pancreatic cancer	3.5e-05	0.00033	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—STK11—pancreatic cancer	3.47e-05	0.000327	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.4e-05	0.000321	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PPARG—pancreatic cancer	3.38e-05	0.000319	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PRSS1—pancreatic cancer	3.37e-05	0.000318	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HIF1A—pancreatic cancer	3.36e-05	0.000317	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TSC2—pancreatic cancer	3.35e-05	0.000316	CbGpPWpGaD
Liotrix—ALB—Metabolism—PRSS1—pancreatic cancer	3.35e-05	0.000316	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	3.34e-05	0.000315	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.31e-05	0.000312	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IFNA2—pancreatic cancer	3.29e-05	0.00031	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—APOE—pancreatic cancer	3.28e-05	0.000309	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.26e-05	0.000307	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CB—pancreatic cancer	3.24e-05	0.000306	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KDR—pancreatic cancer	3.21e-05	0.000303	CbGpPWpGaD
Liotrix—TTR—Disease—PTGS2—pancreatic cancer	3.21e-05	0.000303	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.19e-05	0.000301	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	3.09e-05	0.000291	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CD—pancreatic cancer	3.08e-05	0.00029	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NFKBIA—pancreatic cancer	3.06e-05	0.000288	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NOTCH1—pancreatic cancer	3.03e-05	0.000286	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CD44—pancreatic cancer	3.03e-05	0.000285	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.01e-05	0.000284	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—TYMS—pancreatic cancer	2.99e-05	0.000282	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.96e-05	0.00028	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CG—pancreatic cancer	2.96e-05	0.000279	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.94e-05	0.000277	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.93e-05	0.000277	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGF—pancreatic cancer	2.93e-05	0.000276	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ARG2—pancreatic cancer	2.92e-05	0.000275	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.91e-05	0.000274	CbGpPWpGaD
Liotrix—ALB—Metabolism—ARG2—pancreatic cancer	2.9e-05	0.000274	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GCG—pancreatic cancer	2.9e-05	0.000274	CbGpPWpGaD
Liotrix—TTR—Disease—CTNNB1—pancreatic cancer	2.87e-05	0.000271	CbGpPWpGaD
Liotrix—TTR—Disease—PTEN—pancreatic cancer	2.8e-05	0.000264	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.8e-05	0.000264	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—STK11—pancreatic cancer	2.73e-05	0.000257	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.72e-05	0.000257	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.69e-05	0.000254	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CB—pancreatic cancer	2.68e-05	0.000253	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—pancreatic cancer	2.66e-05	0.000251	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.63e-05	0.000248	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CD—pancreatic cancer	2.6e-05	0.000245	CbGpPWpGaD
Liotrix—TTR—Disease—SRC—pancreatic cancer	2.6e-05	0.000245	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CD44—pancreatic cancer	2.59e-05	0.000244	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.56e-05	0.000242	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMP—pancreatic cancer	2.55e-05	0.000241	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ARG2—pancreatic cancer	2.54e-05	0.00024	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMP—pancreatic cancer	2.54e-05	0.000239	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.54e-05	0.000239	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.51e-05	0.000237	CbGpPWpGaD
Liotrix—TTR—Disease—STAT3—pancreatic cancer	2.5e-05	0.000236	CbGpPWpGaD
Liotrix—TTR—Disease—NRAS—pancreatic cancer	2.5e-05	0.000236	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GCG—pancreatic cancer	2.48e-05	0.000234	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	2.47e-05	0.000233	CbGpPWpGaD
Liotrix—THRA—Gene Expression—AKT1—pancreatic cancer	2.44e-05	0.00023	CbGpPWpGaD
Liotrix—THRB—Gene Expression—AKT1—pancreatic cancer	2.44e-05	0.00023	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.44e-05	0.00023	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—APOE—pancreatic cancer	2.43e-05	0.000229	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	2.41e-05	0.000227	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.37e-05	0.000224	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—TYMS—pancreatic cancer	2.35e-05	0.000221	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PLAU—pancreatic cancer	2.33e-05	0.00022	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—STK11—pancreatic cancer	2.33e-05	0.00022	CbGpPWpGaD
Liotrix—TTR—Disease—MYC—pancreatic cancer	2.33e-05	0.000219	CbGpPWpGaD
Liotrix—TTR—Disease—TGFB1—pancreatic cancer	2.32e-05	0.000219	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTEN—pancreatic cancer	2.32e-05	0.000219	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.3e-05	0.000217	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—pancreatic cancer	2.28e-05	0.000215	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CB—pancreatic cancer	2.27e-05	0.000214	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMP—pancreatic cancer	2.22e-05	0.00021	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.21e-05	0.000208	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CG—pancreatic cancer	2.19e-05	0.000207	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.19e-05	0.000207	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.18e-05	0.000206	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CXCL8—pancreatic cancer	2.18e-05	0.000206	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.18e-05	0.000205	CbGpPWpGaD
Liotrix—TTR—Disease—KRAS—pancreatic cancer	2.15e-05	0.000203	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.13e-05	0.000201	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PPARG—pancreatic cancer	2.12e-05	0.0002	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.11e-05	0.000199	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.09e-05	0.000197	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CASP3—pancreatic cancer	2.09e-05	0.000197	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CG—pancreatic cancer	2.08e-05	0.000196	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GLP1R—pancreatic cancer	2.06e-05	0.000194	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EGF—pancreatic cancer	2.05e-05	0.000194	CbGpPWpGaD
Liotrix—ALB—Metabolism—GLP1R—pancreatic cancer	2.05e-05	0.000193	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.03e-05	0.000192	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCND1—pancreatic cancer	2.03e-05	0.000192	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—DPYD—pancreatic cancer	2.02e-05	0.000191	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.02e-05	0.00019	CbGpPWpGaD
Liotrix—ALB—Metabolism—DPYD—pancreatic cancer	2.01e-05	0.00019	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CTNNB1—pancreatic cancer	2.01e-05	0.00019	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TYMS—pancreatic cancer	2.01e-05	0.000189	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—pancreatic cancer	1.98e-05	0.000186	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—pancreatic cancer	1.97e-05	0.000186	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—pancreatic cancer	1.96e-05	0.000185	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CD—pancreatic cancer	1.93e-05	0.000182	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.92e-05	0.000181	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC2A2—pancreatic cancer	1.91e-05	0.00018	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—APOE—pancreatic cancer	1.91e-05	0.00018	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.9e-05	0.000179	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.89e-05	0.000178	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1.88e-05	0.000177	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.85e-05	0.000175	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.83e-05	0.000173	CbGpPWpGaD
Liotrix—TTR—Disease—HRAS—pancreatic cancer	1.83e-05	0.000172	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CD—pancreatic cancer	1.83e-05	0.000172	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.82e-05	0.000172	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SRC—pancreatic cancer	1.82e-05	0.000171	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.81e-05	0.00017	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.79e-05	0.000169	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.79e-05	0.000169	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—pancreatic cancer	1.77e-05	0.000167	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—DPYD—pancreatic cancer	1.76e-05	0.000166	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—pancreatic cancer	1.75e-05	0.000165	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NRAS—pancreatic cancer	1.75e-05	0.000165	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	1.72e-05	0.000162	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CB—pancreatic cancer	1.68e-05	0.000158	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.67e-05	0.000158	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.67e-05	0.000158	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—pancreatic cancer	1.67e-05	0.000157	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PPARG—pancreatic cancer	1.66e-05	0.000157	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.66e-05	0.000157	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—pancreatic cancer	1.64e-05	0.000154	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—APOE—pancreatic cancer	1.63e-05	0.000154	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—pancreatic cancer	1.63e-05	0.000154	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFB1—pancreatic cancer	1.63e-05	0.000153	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—pancreatic cancer	1.61e-05	0.000152	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—pancreatic cancer	1.59e-05	0.00015	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CB—pancreatic cancer	1.59e-05	0.00015	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.55e-05	0.000146	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.54e-05	0.000145	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	1.51e-05	0.000143	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.51e-05	0.000143	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—pancreatic cancer	1.51e-05	0.000142	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CD44—pancreatic cancer	1.49e-05	0.00014	CbGpPWpGaD
Liotrix—ALB—Metabolism—CD44—pancreatic cancer	1.48e-05	0.000139	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	1.47e-05	0.000139	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.46e-05	0.000137	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—pancreatic cancer	1.45e-05	0.000137	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.45e-05	0.000137	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.44e-05	0.000136	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.44e-05	0.000135	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GCG—pancreatic cancer	1.43e-05	0.000134	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PPARG—pancreatic cancer	1.42e-05	0.000134	CbGpPWpGaD
Liotrix—ALB—Metabolism—GCG—pancreatic cancer	1.42e-05	0.000134	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—pancreatic cancer	1.38e-05	0.00013	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—STK11—pancreatic cancer	1.34e-05	0.000126	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—pancreatic cancer	1.34e-05	0.000126	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—pancreatic cancer	1.34e-05	0.000126	CbGpPWpGaD
Liotrix—ALB—Metabolism—STK11—pancreatic cancer	1.33e-05	0.000126	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	1.32e-05	0.000124	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	1.31e-05	0.000123	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CD44—pancreatic cancer	1.3e-05	0.000122	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	1.3e-05	0.000122	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HRAS—pancreatic cancer	1.28e-05	0.000121	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SRC—pancreatic cancer	1.28e-05	0.00012	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.26e-05	0.000119	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.25e-05	0.000118	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GCG—pancreatic cancer	1.24e-05	0.000117	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—pancreatic cancer	1.24e-05	0.000117	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NRAS—pancreatic cancer	1.23e-05	0.000116	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—STK11—pancreatic cancer	1.17e-05	0.00011	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.15e-05	0.000109	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMS—pancreatic cancer	1.15e-05	0.000108	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—pancreatic cancer	1.14e-05	0.000108	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TGFB1—pancreatic cancer	1.14e-05	0.000107	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—pancreatic cancer	1.13e-05	0.000107	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	1.13e-05	0.000106	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	1.12e-05	0.000105	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—pancreatic cancer	1.06e-05	9.95e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—pancreatic cancer	1.02e-05	9.66e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMS—pancreatic cancer	1e-05	9.48e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—pancreatic cancer	9.76e-06	9.2e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—pancreatic cancer	9.7e-06	9.14e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—pancreatic cancer	9.38e-06	8.85e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—APOE—pancreatic cancer	9.38e-06	8.85e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—APOE—pancreatic cancer	9.33e-06	8.8e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HRAS—pancreatic cancer	8.97e-06	8.46e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.88e-06	8.37e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.83e-06	8.33e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	8.47e-06	7.98e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CG—pancreatic cancer	8.42e-06	7.94e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—pancreatic cancer	8.37e-06	7.89e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—APOE—pancreatic cancer	8.17e-06	7.71e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PPARG—pancreatic cancer	8.17e-06	7.7e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PPARG—pancreatic cancer	8.13e-06	7.66e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	8.05e-06	7.59e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—pancreatic cancer	7.92e-06	7.47e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	7.44e-06	7.02e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CD—pancreatic cancer	7.4e-06	6.98e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CG—pancreatic cancer	7.38e-06	6.95e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PPARG—pancreatic cancer	7.12e-06	6.71e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	6.88e-06	6.49e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—pancreatic cancer	6.58e-06	6.2e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	6.49e-06	6.12e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CD—pancreatic cancer	6.48e-06	6.11e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CB—pancreatic cancer	6.45e-06	6.08e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—pancreatic cancer	6.43e-06	6.06e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—pancreatic cancer	6.39e-06	6.03e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.65e-06	5.33e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—pancreatic cancer	5.62e-06	5.3e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—pancreatic cancer	5.61e-06	5.29e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—pancreatic cancer	5.6e-06	5.28e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—pancreatic cancer	5.57e-06	5.26e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—pancreatic cancer	4.88e-06	4.6e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	3.95e-06	3.73e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—pancreatic cancer	3.93e-06	3.71e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.45e-06	3.25e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—pancreatic cancer	3.23e-06	3.05e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—pancreatic cancer	3.21e-06	3.03e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—pancreatic cancer	2.81e-06	2.65e-05	CbGpPWpGaD
